Newamsterdam Pharma Company N.V. (NAMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 491,323 | 771,743 | 340,450 | 467,728 | 1,227 |
| Marketable Securities | 146,239 | 62,447 | N/A | N/A | N/A |
| Receivables | N/A | 4,951 | N/A | N/A | N/A |
| TOTAL | $675,700 | $863,413 | $346,791 | $477,979 | $1,488 |
| Non-Current Assets | |||||
| PPE Net | 383 | 242 | 46 | 34 | N/A |
| Investments And Advances | 92,609 | 0 | 0 | 0 | 138,017 |
| Intangibles | 407 | 534 | 170 | 208 | 0 |
| Other Non-Current Assets | 185 | 431 | 90 | 276 | 0 |
| TOTAL | $93,584 | $1,207 | $306 | $518 | $138,017 |
| Total Assets | $769,284 | $864,620 | $347,097 | $478,497 | $139,505 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,970 | 4,744 | 16,923 | 11,853 | 167 |
| Accrued Expenses | 15,422 | 13,608 | 11,398 | 6,117 | 55 |
| Other current liabilities | 57,272 | 82,312 | 12,574 | 4,147 | N/A |
| TOTAL | $85,787 | $106,918 | $49,897 | $36,057 | $222 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,987 | 6,008 | 8,942 | 13,874 | N/A |
| Other Non-Current Liabilities | 66 | 202 | 7,788 | 7,582 | 140,813 |
| TOTAL | $66 | $202 | $8,807 | $12,374 | $145,643 |
| Total Liabilities | $85,853 | $107,120 | $58,704 | $48,431 | $145,865 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 109,818 | N/A | 81,560 | 17,751 |
| Common Shares | 14,278 | 13,444 | 10,173 | 10,055 | 0 |
| Retained earnings | -762,390 | -558,571 | -316,973 | -140,036 | -6,360 |
| Other shareholders' equity | 4,793 | 4,467 | 4,422 | 4,422 | 0 |
| TOTAL | $683,431 | $757,500 | $288,393 | $430,066 | $-6,360 |
| Total Liabilities And Equity | $769,284 | $864,620 | $347,097 | $478,497 | $139,505 |